Caris Life Sciences, Inc. (CAI)
26.13
-0.14
(-0.53%)
USD |
NASDAQ |
Aug 24, 16:00
26.15
+0.02
(+0.08%)
After-Hours: 07:53
Caris Life Sciences Enterprise Value : 7.043B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.043B |
| August 21, 2026 | 7.083B |
| August 20, 2026 | 6.605B |
| August 19, 2026 | 6.091B |
| August 18, 2026 | 5.585B |
| August 17, 2026 | 5.772B |
| August 14, 2026 | 5.820B |
| August 13, 2026 | 5.927B |
| August 12, 2026 | 5.950B |
| August 11, 2026 | 6.198B |
| August 10, 2026 | 6.272B |
| August 07, 2026 | 6.085B |
| August 06, 2026 | 5.311B |
| August 05, 2026 | 4.308B |
| August 04, 2026 | 4.209B |
| August 03, 2026 | 4.271B |
| July 31, 2026 | 4.087B |
| July 30, 2026 | 4.206B |
| July 29, 2026 | 4.065B |
| July 28, 2026 | 4.065B |
| July 27, 2026 | 4.076B |
| July 24, 2026 | 4.045B |
| July 23, 2026 | 4.082B |
| July 22, 2026 | 4.005B |
| July 21, 2026 | 4.104B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.056B |
| July 17, 2026 | 4.319B |
| July 16, 2026 | 4.316B |
| July 15, 2026 | 4.593B |
| July 14, 2026 | 4.449B |
| July 13, 2026 | 4.480B |
| July 10, 2026 | 4.460B |
| July 09, 2026 | 4.709B |
| July 08, 2026 | 4.554B |
| July 07, 2026 | 4.596B |
| July 06, 2026 | 4.692B |
| July 02, 2026 | 4.831B |
| July 01, 2026 | 4.958B |
| June 30, 2026 | 4.695B |
| June 29, 2026 | 4.786B |
| June 26, 2026 | 4.837B |
| June 25, 2026 | 4.893B |
| June 24, 2026 | 4.738B |
| June 23, 2026 | 4.582B |
| June 22, 2026 | 4.500B |
| June 18, 2026 | 4.828B |
| June 17, 2026 | 4.656B |
| June 16, 2026 | 4.690B |
| June 15, 2026 | 4.746B |
| June 12, 2026 | 4.687B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CareDx, Inc. | 2.091B |
| Myriad Genetics, Inc. | 386.88M |
| BioRestorative Therapies, Inc. | 1.874M |
| Natera, Inc. | 46.21B |
| Exagen, Inc. | 188.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.637M |
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| EPS Diluted (Quarterly) | -0.0022 |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.42% |
| Operating Earnings Yield | 2.08% |
| Normalized Earnings Yield | 1.702 |